{"id":36976,"date":"2021-11-17T14:06:28","date_gmt":"2021-11-17T14:06:28","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=36976"},"modified":"2021-11-17T14:16:47","modified_gmt":"2021-11-17T14:16:47","slug":"marcus-claesson","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/","title":{"rendered":"Marcus Claesson"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n\n\t<h2>Marcus Claesson<\/h2>\n<h4>Chief Executive Officer at SeqBiome<\/h4>\n\t<p>After a BSc in Chemical Engineering and MSc in Bioinformatics at Chalmers University of Technology in Gothenburg, Marcus completed his PhD at University College Cork (UCC) sequencing and comparing commensal Lactobacillus species. This was followed by postdoctoral fellowships mining probiotic bacteria and analysing the microbiomes of older people as part of the ELDERMET project. Marcus is now a PI at APC Microbiome Ireland, UCC, where his main research interests in the role of microbiota in inflammatory bowel disease, and methods development for &#8216;omics&#8217; technologies. He is also coordinating the MSc programme in Bioinformatics and Computational Biology, and lectures on the subject to MSc, Microbiology and Genetics students. In 2020, Marcus co-founded SeqBiome Ltd, a spin-out company providing high-quality microbiome analysis for industry and academia.<\/p>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery.png\" alt=\"Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery\" onerror=\"this.style.display='none'\"  sizes=\"auto, (max-width: 768px) 100vw, 100vw\" srcset=\"data:image\/svg+xml;utf8,&lt;svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/&gt;\" data-srcset=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery.png 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery-201x300.png 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery-686x1024.png 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery-768x1146.png 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery-630x940.png 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery-420x627.png 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery-315x470.png 315w\" \/>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Unravelling the microbiome of inflammatory bowel disease\n\t<\/h3>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/seqbiome.com\/\" target=\"_blank\" rel=\"noopener\">https:\/\/seqbiome.com\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/marcus-claesson-a4446667\/\" target=\"_blank\" rel=\"noopener\">Visit Profile<\/a><\/p>\n\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Marcus Claesson Chief Executive Officer at SeqBiome After a BSc in Chemical Engineering and MSc in Bioinformatics at Chalmers University of Technology in Gothenburg, Marcus completed his PhD at University College Cork (UCC) sequencing and comparing commensal Lactobacillus species. This was followed by postdoctoral fellowships mining probiotic bacteria and analysing the microbiomes of older people&#8230;<\/p>\n","protected":false},"author":1,"featured_media":36977,"parent":32163,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-36976","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Marcus Claesson &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"After a BSc in Chemical Engineering and MSc in Bioinformatics at Chalmers University of Technology in Gothenburg, Marcus completed his PhD at University College Cork (UCC)\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Marcus Claesson &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"After a BSc in Chemical Engineering and MSc in Bioinformatics at Chalmers University of Technology in Gothenburg, Marcus completed his PhD at University College Cork (UCC)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-17T14:16:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Profile.png\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/\",\"name\":\"Marcus Claesson &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Profile.png\",\"datePublished\":\"2021-11-17T14:06:28+00:00\",\"dateModified\":\"2021-11-17T14:16:47+00:00\",\"description\":\"After a BSc in Chemical Engineering and MSc in Bioinformatics at Chalmers University of Technology in Gothenburg, Marcus completed his PhD at University College Cork (UCC)\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Profile.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Profile.png\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Probiotics, Human &#038; Skin Microbiome Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Marcus Claesson\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Marcus Claesson &#8226; BioTech Pharma Summit","description":"After a BSc in Chemical Engineering and MSc in Bioinformatics at Chalmers University of Technology in Gothenburg, Marcus completed his PhD at University College Cork (UCC)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/","og_locale":"en_US","og_type":"article","og_title":"Marcus Claesson &#8226; BioTech Pharma Summit","og_description":"After a BSc in Chemical Engineering and MSc in Bioinformatics at Chalmers University of Technology in Gothenburg, Marcus completed his PhD at University College Cork (UCC)","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-11-17T14:16:47+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Profile.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/","name":"Marcus Claesson &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Profile.png","datePublished":"2021-11-17T14:06:28+00:00","dateModified":"2021-11-17T14:16:47+00:00","description":"After a BSc in Chemical Engineering and MSc in Bioinformatics at Chalmers University of Technology in Gothenburg, Marcus completed his PhD at University College Cork (UCC)","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Profile.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Marcus_Claesson_BioTech_Pharma_Summit_2021_Profile.png","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/marcus-claesson\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Probiotics, Human &#038; Skin Microbiome Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/"},{"@type":"ListItem","position":3,"name":"Marcus Claesson"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/36976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=36976"}],"version-history":[{"count":3,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/36976\/revisions"}],"predecessor-version":[{"id":36983,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/36976\/revisions\/36983"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32163"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/36977"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=36976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}